NORTHAMPTON, MA / ACCESS Newswire / May 7, 2025 / By Catharine Grimes, President of the Bristol Myers Squibb FoundationWe are in an era of unprecedented medical innovation. Scientists are making remar ...

The Bristol-Myers Squibb Children's Hospital (BMSCH) at Robert Wood Johnson University Hospital (RWJUH) in the US has announced its new Children's Same Day Services centre, aimed at providing ...

We are in an era of unprecedented medical innovation. Scientists are making remarkable progress to diagnose and treat ...

Eight years later, Bristol-Myers acquired Mead Johnson & Company, which was a leader in science-based infant and children's nutrition. Squibb, on the other hand, delved into cancer research ...

Bristol Myers Squibb’s schizophrenia drug Cobnefy failed to meet a primary goal in a phase 3 trial, possibly clouding the drug’s future development. The trial evaluated Cobnefy as an add-on ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the ...

April 24 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab reported ... US FDA aims to remove fluoride supplements for children from market 5:02 PM UTC · Updated ago Healthcare ...

April 22 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab said ... US FDA aims to remove fluoride supplements for children from market 5:02 PM UTC · Updated ago Healthcare ...

Bristol Myers Squibb (BMS), a leading biopharmaceutical ... Director of the Oncology Department of the Nicosia General Hospital, stressed the importance of adhering to international and local ...

The Pediatric Antibiotics Market comprises specialized formulations of beta-lactams, macrolides, cephalosporins, and sulfonamides designed to treat bacterial infections in infants and children. These ...